Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Neuroimaging findings of Zika virus infection: a review article.
Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
Neuroimmunology of a natural disaster.
In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
[Experience of application of Russian biosimilar of interferon beta-1b for treatment of pediatric multiple sclerosis].
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Shared decision-making in multiple sclerosis: A review.
Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis.
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Mast cells: New therapeutic target in helminth immune modulation.
Is fatigue associated with cardiorespiratory endurance among patients suffering from multiple sclerosis?
MRI shows thickening and altered diffusion in the median and ulnar nerves in multifocal motor neuropathy.
Atypical inflammatory demyelinating syndromes of the CNS.
The future of multiple sclerosis treatments.
ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders.
Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells.
Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis.
Textured and stimulating insoles for balance and gait impairments in patients with multiple sclerosis and Parkinson's disease: A systematic review and meta-analysis.
Postural Sway In Persons With Multiple Sclerosis During Passive Heat Exposure: 2018 Board #170 June 2, 2: 00 PM - 3: 30 PM.
Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients.
An atypical presentation of multiple sclerosis.
Pages
« first
‹ previous
…
751
752
753
754
755
756
757
758
759
…
next ›
last »